Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017, Article ID 1373092, 8 pages
https://doi.org/10.1155/2017/1373092
Review Article

Adjuvant Second-Dose Chemotherapy before Surgery for Patients with Locally Advanced Rectal Malignancy Is Not Beneficial: A Systematic Review and Meta-Analysis

Department of General Surgery, Xiamen Traditional Chinese Medicine (TCM) Hospital Affiliated to Fujian University of TCM, Xiamen 361009, China

Correspondence should be addressed to Min Chen; moc.621@nodama

Received 16 April 2017; Revised 26 June 2017; Accepted 4 July 2017; Published 1 August 2017

Academic Editor: Alessandro Passardi

Copyright © 2017 Min Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” CA: A Cancer Journal for Clinicians, vol. 63, pp. 11–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent et al., “Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012,” European Journal of Cancer, vol. 49, pp. 1374–1403, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Heald, E. M. Husband, and R. D. Ryall, “The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?” The British Journal of Surgery, vol. 69, pp. 613–616, 1982. View at Publisher · View at Google Scholar · View at Scopus
  4. W. E. Enker, N. Merchant, A. M. Cohen et al., “Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service,” Annals of Surgery, vol. 230, pp. 544–554, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. C. A. Maurer, P. Renzulli, C. Kull et al., “The impact of the introduction of total mesorectal excision on local recurrence rate and survival in rectal cancer: long-term results,” Annals of Surgical Oncology, vol. 18, pp. 1899–1906, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. W. van Gijn, C. A. Marijnen, I. D. Nagtegaal et al., “Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial,” The Lancet Oncology, vol. 12, pp. 575–582, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Vignali and P. De Nardi, “Multidisciplinary treatment of rectal cancer in 2014: where are we going?” World Journal of Gastroenterology, vol. 20, pp. 11249–11261, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Francois, C. J. Nemoz, J. Baulieux et al., “Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial,” Journal of Clinical Oncology, vol. 17, pp. 2396–2402, 1999. View at Publisher · View at Google Scholar
  9. C. A. M. Marijnen, I. D. Nagtegaal, E. Klein Kranenbarg et al., “No downstaging after short-term preoperative radiotherapy in rectal cancer patients,” Journal of Clinical Oncology, vol. 19, pp. 1976–1984, 2001. View at Publisher · View at Google Scholar
  10. W. Graf, M. Dahlberg, M. M. Osman, L. Holmberg, L. Påhlman, and B. Glimelius, “Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients,” Radiotherapy and Oncology, vol. 43, pp. 133–137, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Horn, J. F. Halvorsen, and O. Dahl, “Preoperative radiotherapy in operable rectal cancer,” Diseases of the Colon and Rectum, vol. 33, pp. 823–828, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. J. E. Byfield, P. Calabro Jones, I. Klisak, and F. Kulhanian, “Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays,” International Journal of Radiation Oncology Biology Physics, vol. 8, pp. 1923–1933, 1982. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Ceelen, K. Fierens, Y. Van Nieuwenhove, and P. Pattyn, “Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis,” International Journal of Cancer, vol. 124, pp. 2966–2972, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Sauer, H. Becker, W. Hohenberger et al., “Preoperative versus postoperative chemoradiotherapy for rectal cancer,” The New England Journal of Medicine, vol. 351, pp. 1731–1740, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. H. Lee, J. S. Kim, J. Y. Kim, J. Jang, C. N. Kim, and W. J. Choi, “Prospective study of additional chemotherapy to preoperative chemoradiotherapy with capecitabine; increased complete response rate and acceptable toxicity,” Colorectal Disease, vol. 15, p. 84, 2013. View at Google Scholar
  16. C. Fernández-Martos, C. Pericay, J. Aparicio et al., “Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study,” Journal of Clinical Oncology, pp. 859–865, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. P. T. Higgins and D. G. Altman, “Assessing risk of bias in included studies,” in In Cochrane Handbook for Systematic Reviews of Interventions, pp. 187–241, John Wiley & Sons, Ltd, 2008. View at Google Scholar
  18. J. F. Bosset, L. Collette, G. Calais et al., “Chemotherapy with preoperative radiotherapy in rectal cancer,” The New England Journal of Medicine, vol. 355, pp. 1114–1123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Maas, P. J. Nelemans, V. Valentini et al., “Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data,” The Lancet Oncology, vol. 11, pp. 835–844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. L. J. Kuo, M. C. Liu, J. J. Jian et al., “Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?” Annals of Surgical Oncology, vol. 14, pp. 2766–2772, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. R. S. Chari, D. S. Tyler, M. S. Anscher et al., “Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum,” Annals of Surgery, vol. 221, pp. 778–787, 1995. View at Publisher · View at Google Scholar
  22. J. P. Ciria, M. Eguiguren, S. Cafiero et al., “Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma?” Reports of Practical Oncology and Radiotherapy, vol. 20, no. 1, pp. 1–11, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. “Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials,” Lancet, vol. 358, pp. 1291–1304, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Jakobsen, J. Ploen, T. Vuong, A. Appelt, J. Lindebjerg, and S. R. Rafaelsen, “Dose-effect relationship in chemoradiotherapy for locally advanced rectal cancer: a randomized trial comparing two radiation doses,” International Journal of Radiation Oncology, Biology, Physics, vol. 84, pp. 949–954, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. A. L. Appelt, I. R. Vogelius, J. Ploen et al., “Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost,” In International Journal of Radiation Oncology Biology Physics, pp. 110–118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Petrelli, G. Sgroi, E. Sarti, and S. Barni, “Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a meta-analysis of published studies,” Annals of Surgery, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Chau, G. Brown, D. Cunningham et al., “Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer,” Journal of Clinical Oncology, vol. 24, pp. 668–674, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Habr-Gama, R. O. Perez, I. Proscurshim et al., “Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome?” International Journal of Radiation Oncology, Biology, Physics, vol. 71, pp. 1181–1188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Aschele, M. L. Friso, S. Pucciarelli et al., “A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer,” Annals of Oncology, vol. 16, pp. 1140–1146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Marechal, B. Vos, M. Polus et al., “Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study,” Annals of Oncology, vol. 23, pp. 1525–1530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Moore, P. Hewett, E. Murphy et al., “Preoperative chemotherapy following neoadjuvant chemoradiotherapy for rectal cancer does not improve pCR rates,” Colorectal Disease, vol. 16, pp. 15-16, 2014. View at Google Scholar
  32. F. A. Calvo, F. J. Serrano, J. A. Diaz-Gonzalez et al., “Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation,” Annals of Oncology, vol. 17, pp. 1103–1110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Garcia-Aguilar, O. S. Chow, D. D. Smith et al., “Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial,” The Lancet Oncology, vol. 16, pp. 957–966, 2015. View at Publisher · View at Google Scholar · View at Scopus